Mati Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $165K

Mati Therapeutics General Information

Description

Developer of drug delivery tools intended to treat medical treatment for age-related macular degeneration. The company's tools use tear film technology to deliver drugs to the surface of the eye, providing healthcare professionals with therapeutic agents for dry eye syndrome as well as ocular allergies

Contact Information

Website
www.matitherapeutics.com
Formerly Known As
10152012, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 Colorado Avenue
  • Suite 2409
  • Austin, TX 78701
  • United States
+1 (512)
Primary Industry
Drug Delivery
Corporate Office
  • 101 Colorado Avenue
  • Suite 2409
  • Austin, TX 78701
  • United States
+1 (512)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mati Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 23-May-2019 $165K Completed Startup
3. Later Stage VC 10-Oct-2018 Completed Startup
2. Early Stage VC 07-Oct-2014 $150K $1.46M Completed Startup
1. Seed Round 12-Apr-2013 $1.31M $1.31M Completed Startup
To view Mati Therapeutics’s complete valuation and funding history, request access »

Mati Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug delivery tools intended to treat medical treatment for age-related macular degeneration. The company's
Drug Delivery
Austin, TX

Princeton, NJ
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mati Therapeutics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TearClear Venture Capital-Backed Princeton, NJ
Aerie Pharmaceuticals Corporate Backed or Acquired Durham, NC
Ocular Therapeutix Formerly VC-backed Bedford, MA
Clearside Biomedical Formerly VC-backed Alpharetta, GA
PulseSight Therapeutics Venture Capital-Backed Paris, France
You’re viewing 5 of 7 competitors. Get the full list »

Mati Therapeutics Patents

  • 239

    Total Documents Applications and Grants

  • Total Patents Families

  • 162

    Granted

  • 23

    Pending

  • Expiring in next 12 mo

Mati Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3095460-A1 Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment Pending 29-Mar-2018
AU-2019245436-A1 Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment Pending 29-Mar-2018
EP-3773330-A4 Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment Pending 29-Mar-2018
EP-3773330-A1 Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment Pending 29-Mar-2018
US-20210023165-A1 Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment Inactive 13-Feb-2018 A61K38/13
To view Mati Therapeutics’s complete patent history, request access »

Mati Therapeutics Executive Team (4)

Name Title Board Seat
Robert Butchofsky II Co-Founder, Chief Executive Officer, President, Secretary & Board Member
Cameron Nelson Chief Financial Officer
Christopher Muller Founding Member, Chief Operating Officer, Chief Commercial Officer & Board Member
Deepank Utkhede Chief Scientific Officer & Board Member
To view Mati Therapeutics’s complete executive team members history, request access »

Mati Therapeutics Board Members (2)

Name Representing Role Since
Deepank Utkhede Mati Therapeutics Chief Scientific Officer & Board Member
Robert Butchofsky II Mati Therapeutics Co-Founder, Chief Executive Officer, President, Secretary & Board Member
To view Mati Therapeutics’s complete board members history, request access »

Ready to get started?

Request a free trial

Mati Therapeutics FAQs

  • When was Mati Therapeutics founded?

    Mati Therapeutics was founded in 2012.

  • Who is the founder of Mati Therapeutics?

    Robert Butchofsky II is the founder of Mati Therapeutics.

  • Who is the CEO of Mati Therapeutics?

    Robert Butchofsky II is the CEO of Mati Therapeutics.

  • Where is Mati Therapeutics headquartered?

    Mati Therapeutics is headquartered in Austin, TX.

  • What industry is Mati Therapeutics in?

    Mati Therapeutics’s primary industry is Drug Delivery.

  • Is Mati Therapeutics a private or public company?

    Mati Therapeutics is a Private company.

  • What is Mati Therapeutics’s current revenue?

    The current revenue for Mati Therapeutics is .

  • How much funding has Mati Therapeutics raised over time?

    Mati Therapeutics has raised $1.68M.

  • Who are Mati Therapeutics’s competitors?

    TearClear, Aerie Pharmaceuticals, Ocular Therapeutix, Clearside Biomedical, and PulseSight Therapeutics are some of the 7 competitors of Mati Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »